SCHEMBL25539595

SCHEMBL25539595

CC1(C)c2ccccc2-c2ccc(-c3cc(-c4ccccc4)nc(-c4ccc(-c5cccc6c5C(C)(C)c5ccc7ccccc7c5-6)c5ccccc45)n3)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
RARA P10276 2/20 0.32
RARB P10826 2/20 0.32
ALDH1A1 P00352 5/20 0.32
MAPT P10636 5/20 0.32
HPGD P15428 5/20 0.32
KDM4E B2RXH2 4/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 1/20 0.32
PDK2 Q15119 4/20 0.32
PSD A5PKW4 1/20 0.32
ACACA Q13085 1/20 0.31
ENPP3 O14638 1/20 0.31
ENPP1 P22413 1/20 0.31
NTSR1 P30989 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539600 0.97 ALDH1A1 (0.34) PIM1CYP1A1CYP1B1RARARARB
SCHEMBL25539591 0.94 MAPT (0.32) PIM1ALDH1A1MAPTHPGDKDM4E
SCHEMBL25537101 0.93 MEN1 (0.34) PIM1CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL25539561 0.93 CYP1A1 (0.34) PIM1CYP1A1CYP1B1RARARARB
SCHEMBL25540305 0.93 CYP1A1 (0.34) PIM1CYP1A1CYP1B1RARARARB
SCHEMBL25540457 0.93 CYP1A1 (0.34) PIM1CYP1A1CYP1B1RARARARB
SCHEMBL25539555 0.93 CYP1A1 (0.34) PIM1CYP1A1CYP1B1RARARARB
SCHEMBL25539551 0.93 MAPT (0.35) PIM1CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL25540303 0.93 MAPT (0.35) PIM1CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL25539586 0.92 CYP1A1 (0.34) PIM1CYP1A1CYP1B1RARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM PIM1 1763/4885CYP1A1 888/4885CYP1B1 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.